BeStock  
Markets › Compare › BIIB vs MRK

BIIB vs MRK

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BIIB · Biogen$224.65 ▼ 0.55%
MRK · Merck & Co$144.14 ▼ 0.81%

Head to head

MetricBIIBMRK
Price$224.65$144.14
Change today▼ 0.55%▼ 0.81%
Market cap$33.19B$355.62B
Return, 3 months–+15.0%
Return, year to date–+38.9%
Return, 1 year–+63.7%
P/E (TTM)39.9115.3
P/B1.88.5
P/E percentile vs own 5y100th89th
Dividend yield–2.33%
Revenue growth (YoY, latest qtr)+3.4%+5.1%
Net profit growth (YoY)-84.6%-130.2%
Gross margin74.0%73.0%
Operating margin19.3%10.5%
Net margin8.3%4.8%
Return on equity4.6%7.0%
Analyst target vs. price+6.8%+13.2%
Analyst buy share65%83%
RSI (14)–48
30-day volatility–42.4%
Max drawdown, 1 year–-11.4%
Trend read–Leaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MRK is the largest of the group by market value.
  • BIIB carries the lowest trailing P/E.
  • MRK is growing revenue fastest.
  • BIIB keeps the most profit per dollar of sales.

Go deeper

Scroll to Top